Michael Zapor, MD, PhD, CTropMed, CPE – Medium

Michael Zapor, MD, PhD, CTropMed, CPE

Michael Zapor, MD, PhD, CTropMed, CPE

Monkeypox: a brief overview (7 July 2022)

As the COVID-19 pandemic crosses the two-and-a-half-year mark, another unrelated virus is now garnering international attention and…

8 min readJul 7, 2022

--

Monkeypox: a brief overview (7 July 2022)

--

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: Pursuit of a universal coronavirus vaccine (4 January 2022)

The emergence of vaccine evasive SARS-CoV-2 variants, coupled with previous coronavirus outbreaks caused by severe acute respiratory…

10 min readJan 4, 2022

--

--

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: A look at the data supporting COVID vaccination of 5–11-year-old children (8 November…

On 29 October 2021, the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for use of the Pfizer-BioNTech…

7 min readNov 8, 2021

--

1

--

1

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: Addressing some common concerns contributing to COVID-19 vaccine hesitancy (14 September…

Considerable time has passed since I published my last COVID-19-themed post, a delay due in large part to my professional obligations as a…

22 min readSep 13, 2021

--

--

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: A musing for the detractors of masking and vaccination (9 April 2021)

There is a popular trend on social media to portray people who refuse to wear masks or get the COVID vaccine as brave non-conformists, and…

5 min readApr 9, 2021

--

--

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: Synopsis of three notable SARS-CoV-2 variants of concern (5 March 2021)

Three COVID-19 vaccines currently have emergency use authorization (EUA) from the Food and Drug Administration (FDA). These include…

8 min readMar 3, 2021

--

1

--

1

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: Synopsis of the available and likely soon to be available COVID-19 vaccines (9 February…

In several prior posts, I describe the conventional sequence of vaccine development (i.e. pre-clinical research, Phase 1, 2, and 3…

13 min readFeb 9, 2021

--

1

--

1

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: The Russian COVID-19 Vaccine Candidate (6 September 2020)

In several prior posts, I describe the research underway to produce a vaccine against SARS-CoV-2, the virus that causes COVID-19 (1,2)…

7 min readSep 6, 2020

--

--

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: Hydroxychloroquine Reviewed (15 August 2020)

One of the hot button topics being discussed nowadays is the utility of hydroxychloroquine in the treatment of patients infected with…

9 min readAug 9, 2020

--

1

--

1

Michael Zapor, MD, PhD, CTropMed, CPE

COVID-19: The Dilemma of Reopening Schools (1 August 2020)

One of the most pressing COVID-19-related questions currently being debated on both the local and national level is whether schools should…

9 min readJul 30, 2020

--

--

Michael Zapor, MD, PhD, CTropMed, CPE

Michael Zapor, MD, PhD, CTropMed, CPE

Dr. Zapor is a microbiologist, infectious diseases physician, and retired Army officer. He resides in West Virginia and in his spare time, he enjoys writing.

Help
Status
About
Careers
Blog
Privacy
Terms
Text to speech
Teams